OMCL - Omnicell Inc logo

OMCL

Omnicell Inc

Omnicell, Inc. provides healthcare technology focused on medication management, offering automated dispensing systems, IV compounding services, specialty pharmacy solutions, and software platforms for health systems and pharmacies to optimize medication workflows.

โš•๏ธ Healthcare NASDAQ Listed 2001 $ USD
$1,000 invested 20 years ago โ†’$1,916today

Score Overview

1 Year
Score
Net Growth19x
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth5.22%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score4.1
Net Growth-49.80%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth10.13%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth64x
Net Trend60%
Net Income Consistency
Rev Growth80.00%
Rev Trend70%
Revenue Consistency
20 Years
Score5.5
Net Growth277.07%
Net Trend65%
Net Income Consistency
Rev Growth8x
Rev Trend80%
Revenue Consistency
All Time
Score
Net Growth35x
Net Trend64%
Net Income Consistency
Rev Growth14x
Rev Trend80%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Omnicell Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 20 years of fundamentals. OMCL does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 33.87โ€”
1 Year2025-09-26
$ 30.7210.25%
5 Years2021-09-28
$ 148.66-77.22%
10 Years2016-09-28
$ 38.10-11.10%
20 Years2006-09-28
$ 17.6891.57%
All Time2001-08-07
$ 9.51256.15%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 1.24B$ 39M$ 292M
2025$ 1.18B$ 2M$ 196M
2024$ 1.11B$ 12M$ 381M
2023$ 1.14B-$ 20M$ 467M
2022$ 1.29B$ 5M$ 341M
2021$ 1.13B$ 77M$ 359M
2020$ 892M$ 32M$ 496M
2019$ 897M$ 61M$ 136M
2018$ 787M$ 37M$ 67M
2017$ 716M$ 20M$ 32M
2016$ 692M$ 603K$ 54M
2015$ 484M$ 30M$ 82M
2014$ 440M$ 30M$ 125M
2013$ 380M$ 23M$ 104M
2012$ 314M$ 16M$ 62M
2011$ 245M$ 10M$ 199M
2010$ 222M$ 4M$ 183M
2009$ 213M$ 444K$ 169M
2008$ 251M$ 12M$ 120M
2007$ 213M$ 43M$ 169M
2006$ 154M$ 10M$ 60M
2005$ 121M-$ 2M$ 29M
2004$ 123M$ 10M$ 30M
2003$ 102M$ 7M$ 33M
2002$ 87M-$ 5M$ 21M
IPO2001$ 86M-$ 1M$ 23M
OMCL - Omnicell Inc logo

Omnicell Inc fundamental performance

Between 2015 and 2025, revenue grew from $ 484M to $ 1.18B and net income declined from $ 30M to $ 2M. Revenue increased in 7 of those 10 years; net income in 6.

Across Omnicell Inc's full reported history, from 2001 to 2025, revenue grew from $ 86M to $ 1.18B and net income went from -$ 1M to $ 2M. Revenue increased in 80% of the years measured; net income in 64%.

Omnicell Inc currently holds a 20-year HDB Score of 5.5 out of 10. How the HDB Score is calculated.

Membership

Explore OMCL with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies